Documents by Year
1930s (3)
1940s (7)
1950s (5)
1960s (6)
1970s (68)
1980s (275)
1990s (122)
2000s (15)
2010s (1108)
2020s (1)

Other RB norms

GF RB 01/2013:20709
GF RB 01/2013:20709
2.7.9. Determination of the functional state of immunoglobulin Fc fragment
GF RB 01/2013:20710
GF RB 01/2013:20710
2.7.10. Quantitative determination of human coagulation factor VII
GF RB 01/2013:20711
GF RB 01/2013:20711
2.7.11. Quantitative determination of human coagulation factor IX
GF RB 01/2013:20712
GF RB 01/2013:20712
2.7.12. Quantitative determination of heparin in concentrates of coagulation factors
GF RB 01/2013:20713
GF RB 01/2013:20713
2.7.13. Quantitative determination of anti-D-human immunoglobulin
GF RB 01/2013:20714
GF RB 01/2013:20714
2.7.14. Quantitative determination of the antigenic (immunogenic) activity of the hepatitis A vaccine
GF RB 01/2013:20715
GF RB 01/2013:20715
2.7.15. Quantitative determination of hepatitis B vaccine (rDNA)
GF RB 01/2013:20716
GF RB 01/2013:20716
2.7.16. Quantitative determination of pertussis vaccine (cell-free)
GF RB 01/2013:20717
GF RB 01/2013:20717
2.7.17. Quantitative determination of human antithrombin III
GF RB 01/2013:20718
GF RB 01/2013:20718
2.7.18. Quantitative determination of human coagulation factor II
GF RB 01/2013:20719
GF RB 01/2013:20719
2.7.19. Quantitative determination of human coagulation factor X
GF RB 01/2013:20720
GF RB 01/2013:20720
2.7.20. Quantitative determination of inactivated polio vaccine in vivo
GF RB 01/2013:20721
GF RB 01/2013:20721
2.7.21. Quantitative determination of human vilebrand factor
GF RB 01/2013:20722
GF RB 01/2013:20722
2.7.22. Quantitative determination of coagulation factor XI person
GF RB 01/2013:20723
GF RB 01/2013:20723
2.7.23. CD34 cell count
GF RB 01/2013:20724
GF RB 01/2013:20724
2.7.24. Flow cytometry
GF RB 01/2013:20725
GF RB 01/2013:20725
2.7.25. Determination of human plasmin inhibitor content
GF RB 01/2013:20727
GF RB 01/2013:20727
2.7.27. The value of flocculation (Lf) of toxins and toxoids of diphtheria and tetanus (Ramon’s test)
GF RB 01/2013:20728
GF RB 01/2013:20728
2.7.28. Determination of the number of human hematopoietic progenitor cells by colony-forming cells
GF RB 01/2013:20729
GF RB 01/2013:20729
2.7.29. Determination of the number and viability of nucleated cells
GF RB 01/2013:20730
GF RB 01/2013:20730
2.7.30. Quantitative determination of human protein C
GF RB 01/2013:20731
GF RB 01/2013:20731
2.7.31. Quantitative determination of human protein S
GF RB 01/2013:20732
GF RB 01/2013:20732
2.7.32. Quantitative determination of human alpha-1-proteinase inhibitor
GF RB 01/2013:20801
GF RB 01/2013:20801
2.8.1. Ash insoluble in hydrochloric acid
GF RB 01/2013:20803
GF RB 01/2013:20803
2.8.3. Stomatal ratio
GF RB 01/2013:20804
GF RB 01/2013:20804
2.8.4. Swelling ratio
GF RB 01/2013:20805
GF RB 01/2013:20805
2.8.5. Determination of water in essential oils
GF RB 01/2013:20806
GF RB 01/2013:20806
2.8.6. Foreign Esters in Essential Oils
GF RB 01/2013:20807
GF RB 01/2013:20807
2.8.7. Fatty and mineral oils in essential oils
GF RB 01/2013:20808
GF RB 01/2013:20808
2.8.8. The smell and taste of essential oils
GF RB 01/2013:20809
GF RB 01/2013:20809
2.8.9. The residue after evaporation of the essential oil
GF RB 01/2013:20810
GF RB 01/2013:20810
2.8.10. Solubility of essential oils in alcohol
GF RB 01/2013:20811
GF RB 01/2013:20811
2.8.11. Determination of 1,8-cineol in essential oils
GF RB 01/2013:20812
GF RB 01/2013:20812
2.8.12. Determination of essential oil in medicinal plant materials
GF RB 01/2013:20813
GF RB 01/2013:20813
2.8.13. Pesticide residues
GF RB 01/2013:20814
GF RB 01/2013:20814
2.8.14. Determination of tannins
GF RB 01/2013:20815
GF RB 01/2013:20815
2.8.15. Definition of bitterness
GF RB 01/2013:20816
GF RB 01/2013:20816
2.8.16. Dry residue extracts
GF RB 01/2013:20817
GF RB 01/2013:20817
2.8.17. Loss on drying of the extract
GF RB 01/2013:20818
GF RB 01/2013:20818
2.8.18. The definition of aflatoxin B1 in medicinal plant materials
GF RB 01/2013:20820
GF RB 01/2013:20820
2.8.20. Medicinal plant materials: sampling
GF RB 01/2013:20822
GF RB 01/2013:20822
2.8.22. Determination of ochratoxin A in medicinal plant materials
GF RB 01/2013:20823
GF RB 01/2013:20823
2.8.23. # Macroscopic and # microscopic analysis of medicinal plant materials
GF RB 01/2013:20901
GF RB 01/2013:20901
2.9.1. Disintegration of tablets and capsules
GF RB 01/2013:20902
GF RB 01/2013:20902
2.9.2. Disintegration of suppositories and pessaries
GF RB 01/2013:20903
GF RB 01/2013:20903
2.9.3. Dissolution test for solid dosage forms
GF RB 01/2013:20904
GF RB 01/2013:20904
2.9.4. Dissolution test for transdermal patches
GF RB 01/2013:20905
GF RB 01/2013:20905
2.9.5. Mass uniformity per unit of dosage unit

All Codes and Regulations

GOST RB PUE RB Decrees RB Letters SNB RB TR EAES
MSP RB Codes RB Instructions RB Orders STB RB
Other RB norms RB Decisions RB Laws RB Resolutions TKP

All Categories

Construction (Max) Highways (Max) National Standards for KGS (State Standards Classification) Projects of works (PPR) on bridges Technical Supervision
Construction Price Formation ISO classifier Organization Standards PromExpert Welding regulations
Evidence base (TR CU, Technical Regulation of the Customs Union) National standards Power industry Standards for pipe fittings (TPA)

Send us a message Expand Collapse

Leave your message in the form below, and we will write back by e-mail!